Safety and Tolerability of Mebendazole in Infants Under 1 Year of Age,Journal of the Pediatric Infectious Diseases Society

当前位置： X-MOL 学术 › J. Pediat. Inf. Dis. Soc. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Safety and Tolerability of Mebendazole in Infants Under 1 Year of Age
Journal of the Pediatric Infectious Diseases Society ( IF 3.2 ) Pub Date : 2021-09-01 , DOI: 10.1093/jpids/piab077
Yaara Kahan _{1,

2} , Eve Lugassy-Akian _{2,

3} , Adi Ovadia _{2,

3} , Ilan Dalal _{2,

3} , Eli Somekh _{2,

4} , Diana Tasher _{1,

2}

Affiliation

This paper presents the largest cohort to date of infants under 1 year of age treated with mebendazole. We evaluated the occurrence of mebendazole-associated clinical and laboratory toxicity as safety data in this age group are currently lacking.

中文翻译：